{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:39Z","timestamp":1759334679828,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jfo.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T08:33:55Z","timestamp":1606898035000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating the efficacy and safety of oral spironolactone in patients with central serous chorioretinopathy"],"prefix":"10.1016","volume":"44","author":[{"given":"S.","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Balsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2020.09.003_bib0145","first-page":"1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63Suppl","author":"Gass","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0150","unstructured":"Kitzmann AS, Pulido JS, Diehl NN et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002."},{"key":"10.1016\/j.jfo.2020.09.003_bib0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","article-title":"Systemic findings associated with central serous chorioretinopathy","volume":"128","author":"Tittl","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Lew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0170","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretionopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J Clin \u0130nvest"},{"key":"10.1016\/j.jfo.2020.09.003_bib0175","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target aldosterone up-regulates ion and water channels in M\u00fcller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"Faseb J"},{"key":"10.1016\/j.jfo.2020.09.003_bib0180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0185","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative Study Group. Research and Education Committee and Website Committee. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2020.09.003_bib0190","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/eye.2015.58","article-title":"Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients","volume":"29","author":"Kim","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jfo.2020.09.003_bib0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/15569527.2013.812104","article-title":"Morphologic changes and visual outcomes in resolved central serous chorioretinopathy treated with ranibizumab","volume":"33","author":"Ozdemir","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new phsyiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2020.09.003_bib0205","first-page":"800","article-title":"High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension","volume":"127","author":"Mosso","year":"1999","journal-title":"Rev Med Chill"},{"key":"10.1016\/j.jfo.2020.09.003_bib0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2020.09.003_bib0215","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.05-0268","article-title":"Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy","volume":"46","author":"Tittl","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2020.09.003_bib0220","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archopht.121.7.975","article-title":"Topical fundus pulsation measurement in patients with active central serous chorioretinopathy","volume":"121","author":"Tittl","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0225","first-page":"1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63Suppl","author":"Gass","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0230","first-page":"1","article-title":"Spironolactone versus observation in the treatment of acute central serous chorioretinopathy","volume":"0","author":"Sun","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2020.09.003_bib0240","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/eye.2016.79","article-title":"Taskapili. The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study","volume":"30","author":"Ozkaya","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jfo.2020.09.003_bib0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00417-016-3436-5","article-title":"Long-term results and recurrence rates after spironolactone treatement in non-resolving central serous chorioretinopathy","volume":"255","author":"Herold","year":"2017","journal-title":"Graefs Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0250","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2020.09.003_bib0255","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.2010.182121","article-title":"Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulati\u0131on or photodynamic therapy","volume":"95","author":"Lim","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0260","first-page":"1","article-title":"Comparison of short-term efficacy between oral spironolactone treatment and phodynamic therapy for the treatment of nonresolving central serous chorioretinopathy","volume":"0","author":"Lee","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2020.09.003_bib0265","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of choronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2020.09.003_bib0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jfo.2020.09.003_bib0275","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2020.09.003_bib0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000055622","article-title":"Regulatory mechanisms in the retinal and choroidal circulation","volume":"32","author":"Delaey","year":"2000","journal-title":"Ophthalmic Res"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220305143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551220305143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:14:15Z","timestamp":1759259655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551220305143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0181551220305143"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2020.09.003","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the efficacy and safety of oral spironolactone in patients with central serous chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}